| 000 | 01239 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517133826.0 | ||
| 264 | 0 | _c20170605 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1080/14728222.2017.1280467 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTan, Chek Kun | |
| 245 | 0 | 0 |
_aSynthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _cMar 2017 |
||
| 300 |
_a333-348 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbohydrate Metabolism _xphysiology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEnergy Metabolism _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aLipid Metabolism _xphysiology |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aPeroxisome Proliferator-Activated Receptors _xagonists |
| 700 | 1 | _aZhuang, Yan | |
| 700 | 1 | _aWahli, Walter | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 21 _gno. 3 _gp. 333-348 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14728222.2017.1280467 _zAvailable from publisher's website |
| 999 |
_c26789465 _d26789465 |
||